======= MED31 =======
== Gene Information ==
* **Official Symbol**: MED31
* **Official Name**: mediator complex subunit 31
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51003|51003]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y3C7|Q9Y3C7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MED31&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MED31|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/620492|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
|Med31|
|core mediator complex|
|negative regulation of fibroblast proliferation|
|mediator complex|
|regulation of fibroblast proliferation|
|ubiquitin ligase complex|
|transcription initiation from RNA polymerase II promoter|
|appendage development|
|limb development|
|DNA-templated transcription, initiation|
|ubiquitin protein ligase activity|
|transcription coactivator activity|
|transcription by RNA polymerase II|
|transcription, DNA-templated|
|nucleic acid-templated transcription|
|RNA biosynthetic process|
|negative regulation of cell population proliferation|
|protein ubiquitination|
|protein modification by small protein conjugation|
|protein modification by small protein conjugation or removal|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|regulation of cell population proliferation|
|cellular nitrogen compound biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|RNA metabolic process|
|cellular macromolecule biosynthetic process|
|positive regulation of RNA metabolic process|
|macromolecule biosynthetic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.28|
|[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.83|
|[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-1.83|
|[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-1.83|
|[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-1.8|
|[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|-1.78|
|[[:results:exp121|Golgicide-A 2μM R03 exp121]]|-1.75|
^Gene^Correlation^
|[[:human genes:m:med16|MED16]]|0.404|
Global Fraction of Cell Lines Where Essential: 3/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|1/20|
|lung|0/75|
|lymphocyte|1/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3721
* **Expression level (log2 read counts)**: 3.2
{{:chemogenomics:nalm6 dist.png?nolink |}}